Authors:
FRAIFELD V
SAMOKOVLISKY A
KAPLANSKI J
GOPAS J
LADIZHENSKY I
KORIN E
Citation: V. Fraifeld et al., HYPERTHERMIA-INDUCED EFFECTS IN DIFFERENT MALIGNANT AND NORMAL-CELL LINES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4531-4531
Authors:
BENHARROCH D
BROUSSET P
GOLDSTEIN J
PRINSLOO I
RABINOVITCH D
SHENDLER Y
ARIAD S
LEVY A
DELSOL G
GOPAS J
Citation: D. Benharroch et al., ASSOCIATION OF THE EPSTEIN-BARR-VIRUS WITH HODGKINS-DISEASE IN SOUTHERN ISRAEL, International journal of cancer, 71(2), 1997, pp. 138-141
Authors:
BENHARROCH D
PRINSLOO I
APTE RN
YERMIAHU T
GEFFEN DB
YANAIINBAR I
GOPAS J
Citation: D. Benharroch et al., INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN THE REED-STERNBERG CELLS OF HODGKINS-DISEASE - CORRELATION WITH CLINICAL AND MORPHOLOGICALINFLAMMATORY FEATURES, European cytokine network, 7(1), 1996, pp. 51-57
Authors:
OKIMOTO T
KOHNO K
KUWANO M
GOPAS J
KUNG HF
ONO M
Citation: T. Okimoto et al., REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR BY ACTIVATED H-RAS ANDV-MYC ONCOGENES IN MOUSE BALB 3T3 CELLS - POSSIBLE ROLES OF AP-1/, Oncogene, 12(8), 1996, pp. 1625-1633
Authors:
BENHARROCH D
PRINSLOO I
GOLDSTEIN J
BROUSSET P
KACHKO L
GOPAS J
Citation: D. Benharroch et al., COMPARISON OF DISTINCT MODES OF TUMOR-CELL DEATH IN HODGKINS-DISEASE USING MORPHOLOGY AND IN-SITU DNA FRAGMENTATION, Ultrastructural pathology, 20(6), 1996, pp. 497-505
Authors:
AVINOACH I
COHEN Y
MANOR E
GALRON D
GOPAS J
Citation: I. Avinoach et al., DIFFERENT EXPRESSION OF P53 AND P16 CDKN2 SUPPRESSOR GENES IN MELANOMA CELL-LINES AND CULTURED MELANOCYTES - CORRELATION WITH CHROMOSOMAL-ABERRATIONS AND TUMOR PROGRESSION PROCESS/, Journal of investigative dermatology, 106(4), 1996, pp. 564-564
Authors:
BROUSSET P
BENHARROCH D
KRAJEWSKI S
LAURENT G
MEGGETTO F
RIGALHUGUET F
GOPAS J
PRINSLOO I
PRIS J
DELSOL G
REED JC
SCHLAIFER D
Citation: P. Brousset et al., FREQUENT EXPRESSION OF THE CELL DEATH-INDUCING GENE BAX IN REED-STERNBERG CELLS OF HODGKINS-DISEASE, Blood, 87(6), 1996, pp. 2470-2475
Authors:
BRKICCIZEL G
ALEXENBERG R
PRIEL E
PELI I
POLAK Y
COHEN Y
GOPAS J
Citation: G. Brkiccizel et al., DRUG-RESISTANCE MECHANISMS TO CISPLATIN IN H-RAS AND V-MYC TRANSFECTED FIBROBLASTS, European journal of cancer, 31A, 1995, pp. 125-125
Authors:
BENHARROCH D
YERMIAHU T
GEFFEN DB
PRINSLOO I
GOPAS J
SEGAL S
ABOUD M
Citation: D. Benharroch et al., EXPRESSION OF C-MYC AND C-RAS ONCOGENES IN THE NEOPLASTIC AND NONNEOPLASTIC CELLS OF HODGKINS-DISEASE, European journal of haematology, 55(3), 1995, pp. 178-183
Citation: Ad. Cohen et al., CA-15-3, MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN AND TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN - CORRELATION TO DISEASE STATE AND PROGNOSIS IN BREAST-CANCER PATIENTS, Israel journal of medical sciences, 31(2-3), 1995, pp. 155-159
Citation: S. Horn et al., MEMBRANE GLYCOPROTEIN MODIFICATIONS OF G6PD DEFICIENT RED-BLOOD-CELLS, European journal of clinical investigation, 25(1), 1995, pp. 32-38
Citation: Ad. Cohen et al., IMMUNOSUPPRESSIVE ACIDIC PROTEIN SERUM LEVELS IN BREAST-CANCER PATIENTS IN A REFERENCE TO CA-15-3 LEVELS, Breast cancer research and treatment, 30(2), 1994, pp. 197-200
Authors:
EHRLICH T
WISHNIAK O
ISAKOV N
COHEN O
SEGAL S
RAGERZISMAN B
GOPAS J
Citation: T. Ehrlich et al., THE EFFECT OF H-RAS EXPRESSION ON TUMORIGENICITY AND IMMUNOGENICITY OF BALB C 3T3 FIBROBLASTS/, Immunology letters, 39(1), 1993, pp. 3-8
Authors:
HARVARDI I
GOPAS J
RAGERZISMAN B
HAMMERLING GJ
SEGAL S
ABOUD M
Citation: I. Harvardi et al., DIFFERENTIAL EXPRESSION OF THE H-2D(K) MHC CLASS-I ANTIGEN AND TISSUEINHIBITOR OF METALLOPROTEINASES IN METASTATIC AND NONMETASTATIC T-10 FIBROSARCOMA CELLS, Invasion & metastasis, 12(5-6), 1992, pp. 301-308